198 related articles for article (PubMed ID: 20865697)
1. Modification of MR molecular imaging probes with cysteine-terminated peptides and their potential for in vivo tumour detection.
Xu F; Lei D; Du X; Zhang C; Xie X; Yin D
Contrast Media Mol Imaging; 2011; 6(1):46-54. PubMed ID: 20865697
[TBL] [Abstract][Full Text] [Related]
2. RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.
Luo Y; Yang J; Yan Y; Li J; Shen M; Zhang G; Mignani S; Shi X
Nanoscale; 2015 Sep; 7(34):14538-46. PubMed ID: 26260703
[TBL] [Abstract][Full Text] [Related]
3. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An
Xu YH; Yang J; Meng J; Wang H
Chin Med Sci J; 2020 Jun; 35(2):142-150. PubMed ID: 32684234
[TBL] [Abstract][Full Text] [Related]
4. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.
Zhang C; Jugold M; Woenne EC; Lammers T; Morgenstern B; Mueller MM; Zentgraf H; Bock M; Eisenhut M; Semmler W; Kiessling F
Cancer Res; 2007 Feb; 67(4):1555-62. PubMed ID: 17308094
[TBL] [Abstract][Full Text] [Related]
5. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
[TBL] [Abstract][Full Text] [Related]
6. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
7. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
[TBL] [Abstract][Full Text] [Related]
8. Improving sensitivity of magnetic resonance imaging by using a dual-targeted magnetic iron oxide nanoprobe.
Chen L; Xie J; Wu H; Zang F; Ma M; Hua Z; Gu N; Zhang Y
Colloids Surf B Biointerfaces; 2018 Jan; 161():339-346. PubMed ID: 29100127
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of iron oxide nanoparticles with RGD-modified dendrimers for targeted tumor MR imaging.
Yang J; Luo Y; Xu Y; Li J; Zhang Z; Wang H; Shen M; Shi X; Zhang G
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5420-8. PubMed ID: 25695661
[TBL] [Abstract][Full Text] [Related]
10. The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI.
Zhang B; Yang B; Zhai C; Jiang B; Wu Y
Biomaterials; 2013 Jul; 34(23):5843-52. PubMed ID: 23642536
[TBL] [Abstract][Full Text] [Related]
11. SPIO-RGD nanoparticles as a molecular targeting probe for imaging tumor angiogenesis using synchrotron radiation.
Li J; Zhang C; Yang K; Liu P; Xu LX
J Synchrotron Radiat; 2011 Jul; 18(Pt 4):612-6. PubMed ID: 21685679
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
Mathejczyk JE; Pauli J; Dullin C; Napp J; Tietze LF; Kessler H; Resch-Genger U; Alves F
Mol Imaging; 2011 Dec; 10(6):469-80. PubMed ID: 22201538
[TBL] [Abstract][Full Text] [Related]
14. Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI.
Chen TJ; Cheng TH; Hung YC; Lin KT; Liu GC; Wang YM
J Biomed Mater Res A; 2008 Oct; 87(1):165-75. PubMed ID: 18085650
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
Ding C; Wu K; Wang W; Guan Z; Wang L; Wang X; Wang R; Liu L; Fan J
Oncotarget; 2017 Jan; 8(3):4718-4729. PubMed ID: 27902468
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
17. Molecular Targeted Magnetic Resonance Imaging of Human Colorectal Carcinoma (LoVo) Cells Using Novel Superparamagnetic Iron Oxide- Loaded Nanovesicles: In Vitro and in vivo Studies.
Feng ST; Li H; Luo Y; Cai H; Dong Z; Fang Z; Shuai X; Li ZP
Curr Cancer Drug Targets; 2016; 16(6):551-60. PubMed ID: 27262319
[TBL] [Abstract][Full Text] [Related]
18. Facile synthesis of RGD peptide-modified iron oxide nanoparticles with ultrahigh relaxivity for targeted MR imaging of tumors.
Hu Y; Li J; Yang J; Wei P; Luo Y; Ding L; Sun W; Zhang G; Shi X; Shen M
Biomater Sci; 2015 May; 3(5):721-32. PubMed ID: 26222591
[TBL] [Abstract][Full Text] [Related]
19. Targeted RGD nanoparticles for highly sensitive in vivo integrin receptor imaging.
Lin RY; Dayananda K; Chen TJ; Chen CY; Liu GC; Lin KL; Wang YM
Contrast Media Mol Imaging; 2012; 7(1):7-18. PubMed ID: 22344875
[TBL] [Abstract][Full Text] [Related]
20. A nanosized delivery system of superparamagnetic iron oxide for tumor MR imaging.
Lee ES; Lim C; Song HT; Yun JM; Lee KS; Lee BJ; Youn YS; Oh YT; Oh KT
Int J Pharm; 2012 Dec; 439(1-2):342-8. PubMed ID: 22959991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
